Rafferty Asset Management
GBIO

Rafferty Asset Management’s Generation Bio GBIO Stock Holding History

Rafferty Asset Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,114
Closed -$82K – 1165
2022
Q1 		$82K Sell
1,114
-10,338
-90% -$599K ﹤0.01% 1186
2021
Q4 		$811K Buy
11,452
+5,424
+90% +$947K ﹤0.01% 966
2021
Q3 		$1.51M Sell
6,028
-2,714
-31% -$650K 0.01% 708
2021
Q2 		$2.35M Sell
8,742
-846
-9% -$253K 0.01% 641
2021
Q1 		$2.73M Buy
+9,588
New +$3.07M 0.02% 544

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Rafferty Asset Management's GBIO Position: Q2 2022 in Review

Rafferty Asset Management sold out of Generation Bio (GBIO) in Q2 2022, closing a stake of 1,114 shares — an estimated $82K sold.

Rafferty Asset Management first reported a position in GBIO in Q1 2021 and held it in 5 quarters. The position peaked at $2.73M in Q1 2021. 91 funds tracked by Wall St. Rank hold GBIO as of Q2 2022.

  • Rafferty Asset Management reported no remaining Generation Bio position as of Q2 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 1,114 Generation Bio shares in Q2 2022, an estimated $82K.
  • Rafferty Asset Management first reported a position in Generation Bio in Q1 2021 and held it in 5 quarters.
  • Rafferty Asset Management's Generation Bio position peaked at $2.73M in Q1 2021.
  • 91 funds tracked by Wall St. Rank held Generation Bio as of Q2 2022.

Based on Rafferty Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.